Author Question: The chorda tympani A) is a blood vessel that first surfaces in the external auditory meatus and ... (Read 87 times)

bobbysung

  • Hero Member
  • *****
  • Posts: 519
The chorda tympani
 A) is a blood vessel that first surfaces in the external auditory meatus and passes into the middle ear space at the inferior margin of the tympanic membrane.
  B) is a branch of the VII facial nerve.
  C) can sometimes be seen through the superior tympanic membrane during otoscopy.
  D) a & b
  E) b & c

Question 2

The pars flaccida is
 A) in the superior quadrant of the tympanic membrane.
  B) between the posterior and anterior malleolar folds.
  C) the most flaccid portion of the tympanic membrane.
  D) a & b
  E) a, b, & c



lin77x

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

E

Answer to Question 2

E



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library